Posted by admin

In 2020, scientists at Harvard took a mouse that had gone blind and gave it its sight back by telling the cells inside it to act young again. Since then, an AI has invented a gene editor that exists nowhere in nature, a machine-designed drug has helped human patients breathe better, and the first therapy that tells human cells to run backwards was put into a living person. This is the story of what happens when biology stops being something we can only watch. Every claim in this video comes from published research and regulatory records, Harvard Medical School, DeepMind, the Arc Institute, the Mayo Clinic, Nature, Nature Medicine, and The Lancet. What you're about to see is the clearest evidence yet that aging is becoming something scientists can engineer rather than endure. Not in a distant future, but in labs and hospitals operating right now. At the same time, nobody has added a single day to a human life yet, and this video is as honest about the failures as it is about the breakthroughs. Timestamps 00:00 - Intro 00:24 - How We Cured Blindness 02:43 - The AI That Learned Biology 04:40 - The People With The Money 07:02 - The Four Crossings For Humans 12:40 - The Machine That Sees It Coming 15:18 - The Ceiling 18:00 - This Already Happened Once 🔔 Subscribe for more AI documentaries 🛠 Explore 49,000+ AI tools: https://theresanaiforthat.com 📚 RESOURCES & FURTHER READING HARVARD MEDICAL SCHOOL — REVERSING VISION LOSS IN MICE * Reprogramming to recover youthful epigenetic information and restore vision (Nature, Dec 2020): https://www.nature.com/articles/s41586-020-2975-4 * Mass Eye and Ear announcement: https://masseyeandear.org/news/press-releases/2020/12/hms-scientists-reverse-age-related-vision-loss-eye-damage-from-glaucoma-in-mice GOOGLE DEEPMIND — ALPHAFOLD * Highly accurate protein structure prediction with AlphaFold (Nature, 2021): https://www.nature.com/articles/s41586-021-03819-2 * AlphaFold: Five Years of Impact: https://deepmind.google/discover/blog/alphafold-five-years-of-impact/ DAVID BAKER / INSTITUTE FOR PROTEIN DESIGN — DESIGNING NEW PROTEINS * De novo design of protein structure and function with RFdiffusion (Nature, 2023): https://www.nature.com/articles/s41586-023-06415-8 ARC INSTITUTE — EVO AND THE AI-DESIGNED GENE EDITOR * Sequence modeling and design from molecular to genome scale with Evo (Science, Nov 2024): https://www.science.org/doi/10.1126/science.ado9336 OPENAI + RETRO BIOSCIENCES — GPT-4b MICRO * OpenAI announcement: https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences/ * MIT Technology Review coverage: https://www.technologyreview.com/2025/01/17/1110086/openai-has-created-an-ai-model-for-longevity-science/ INSILICO MEDICINE — THE FIRST AI-DESIGNED DRUG IN PATIENTS * A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial (Nature Medicine, June 2025): https://www.nature.com/articles/s41591-025-03743-2 UNITY BIOTECHNOLOGY — THE SENOLYTIC FAILURE * PubMed record on senolytics in humans: https://pubmed.ncbi.nlm.nih.gov/31542391/ MAYO CLINIC — AI READING ELECTROCARDIOGRAMS * An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm (The Lancet, 2019): https://pubmed.ncbi.nlm.nih.gov/31378392/ MASAI TRIAL — AI IN BREAST CANCER SCREENING * Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (Lancet Oncology, 2023): https://pubmed.ncbi.nlm.nih.gov/37541274/ THE LIMITS OF HUMAN LIFESPAN * Evidence for a limit to human lifespan (Nature, Oct 2016): https://www.nature.com/articles/nature19793 XENOTRANSPLANTATION — PIG ORGANS IN HUMAN PATIENTS * NYU Langone updates on gene-edited pig kidney transplants: https://nyulangone.org/news